Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - CYCC

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - CYCC

  • Market Cap$64.820m
  • SymbolNASDAQ:CYCC
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS23254L6039

Company Profile

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include CYC065 CDK inhibitor, Sapacitabine and seliciclib, CYC682, CYC140 PLK inhibitor, and CYC202. It earns the majority of its revenue from the United Kingdom.Cyclacel Pharmaceuticals Inc mainly develops targeted medicines for cancer and other proliferative diseases. The company focuses in hematology and oncology-based development pipeline of novel drug candidates.

Latest CYCC news

Currently there for this company. Visit our news hub for other news .